<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="1289">
  <stage>Registered</stage>
  <submitdate>16/05/2006</submitdate>
  <approvaldate>18/05/2006</approvaldate>
  <actrnumber>ACTRN12606000190505</actrnumber>
  <trial_identification>
    <studytitle>Smoking Cessation Program Following Diagnosis of a Potentially Curable Cancer</studytitle>
    <scientifictitle>A prospective cohort study of current and recent ex-smokers offered enrolment in a smoking cessation program following diagnosis of a potentially curable cancer: an examination of factors determining success in quitting and subsequent effect on quality of life</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Potentially curable cancer (any type)</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2 />
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>A motivational interview session with a smoking cessation nurse, for approximately 1.5 hours</interventions>
    <comparator>No comparator.</comparator>
    <control>Uncontrolled</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Prolonged abstience rate</outcome>
      <timepoint>At 12 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Determine prolonged abstinence </outcome>
      <timepoint>At 1, 3 and 6 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Determine point-prevalence abstinence rates </outcome>
      <timepoint>At 1, 3, 6, and 12 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Assess associations between prolonged abstinence status at 12 months and level of nicotine dependence, demongraphic factors, type of cancer, patient readiness to abstain, distress score, quality of life, efficacy of inital anti-cancer treatment, toxicity of inital anti-cancer treatment.</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Compare quitters and non-quitters with respect to change in quality of life and distress</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Identify barriers and difficulties in the quitting process</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Signed informed consent- presence of a potentially curable cancer which is newly diagnosed and histologically confirmed- treatment policy established for curative intent- current smoker or recent ex smoker- ability to participate in the first interview with a quit counsellor within a week of registration- high likelihood of surviving for at least 12 months- available for 12 month follow up- ability to speak, read and write English sufficiently well- access to a telephone at home.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Inital treatment for cancer commenced more than two weeks prior to study registration- active current history of unstable psychiatric illness or significant cognitive deficits.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Educational / counselling / training</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>8/05/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Charities/Societies/Foundations</primarysponsortype>
    <primarysponsorname>Peter MacCallum Cancer Centre</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Foundation grant</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <fundingsource>
      <fundingtype>Other Collaborative groups</fundingtype>
      <fundingname>RACP fellowship grant</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>None</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname> Peter MacCallum Cancer Centre</ethicname>
      <ethicaddress />
      <ethicapprovaldate>23/02/2006</ethicapprovaldate>
      <hrec>06/05</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Linda Mileshkin</name>
      <address>Department of Medical Oncology
Locked Bag 1 A'Beckett St
East Melbourne
Victoria 8006 </address>
      <phone>61 3 9656 3719</phone>
      <fax />
      <email>Linda.Mileshkin@petermac.org</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Anna Ugalde</name>
      <address>Education Centre - Level 3
Locked Bag 1 A'Beckett St
East Melbourne
Victoria 8006 </address>
      <phone>61 3 9656 1798</phone>
      <fax>61 3 9656 1337</fax>
      <email>Anna.Ugalde@petermac.org</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>